SynthesisClinical medicine (London, England)2022
Systematic review of mTOR inhibitor treatment, biomarkers and prophylaxis for tuberous sclerosis complex-associated seizures.
Jingwen ZhangPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.